Medical device lobbyists called for more staffing transparency in user fee negotiations with the Food and Drug Administration ...
Kestrel Therapeutics Inc. ('Kestrel” or the 'Company”), a clinical stage biotechnology company developing next-generation small-molecule inhibitors targeting mutant KRAS, today announced that the U.S.
BrYet US, Inc. (“BrYet”) — a biotechnology innovator focused on developing curative therapies for advanced cancers — ...
Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain ...
The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who ...
The supply chain that ultimately connects patients with their medicines is winding and complex — and growing more consolidated. In recent years, lawmakers have targeted the tactics used by drug ...
The FDA has outlined a proposed approval pathway for customized drugs and gene-editing therapies designed for rare and ...
Will Lissman took over The Honest Kitchen after its founder spent two decades lobbying the FDA to create a human-grade pet ...
The plan raises a number of questions, including how the payments will be distributed across large teams of staffers.
April 10 meeting in Charlotte, NC, co-located with HMP Global’s SAWC Spring | WHS, advances regulatory science and ...
One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results